• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Eli Lilly

Eli Lilly’s Oral GLP-1 Shows Positive Trial Results for Type 2 Diabetes

by Jasmine Pennic 04/17/2025 Leave a Comment

Lilly's Oral GLP-1 Shows Positive Phase 3 Results for Type 2 Diabetes

What You Should Know:  - Eli Lilly and Company announced positive topline Phase 3 results from ACHIEVE-1, a study evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes whose blood sugar was inadequately controlled through diet and exercise alone.  - Orforglipron stands out as the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase 3
Read More

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

by Jasmine Pennic 03/01/2023 Leave a Comment

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

What You Should Know: - Eli Lilly and Company today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or less per month at participating retail pharmacies.  - The historic price cut makes it easier to access Lily insulin for Americans who may have difficulty navigating a complex healthcare system that may keep them from getting affordable
Read More

7 Life Sciences Executive Predictions to Watch in 2023

by Fred Pennic 01/13/2023 Leave a Comment

7 Executive Life Sciences Predictions to Watch in 2023

Tracy Curley, CFO and interim CEO at iSpecimen Focusing on the macroeconomic environment, which remains impacted by the lingering COVID-19 pandemic, there continues to be uncertainty about the strength of the global, Asia Pacific, UK and US economies. High-interest rates and a potential recession remain a concern for all market participants. At ISPC, we are closely monitoring the pace of specimen transactions. We believe that this industry can be resilient through a continued economic
Read More

Prescryptive Health Taps Lilly on First-to-Market Value-Based Program to Stabilize Insulin Pricing

by Jasmine Pennic 12/19/2022 Leave a Comment

Prescryptive Health Taps Lilly on First-to-Market Value-Based Program to Stabilize Insulin Pricing

What You Should Know: - Prescryptive Health, a healthcare technology company on a mission to rewrite the script for the U.S. pharmaceutical market partners with Eli Lilly and Company on a new and first-to-market subscription model to help lower costs for people who pay for their Lilly insulin through their employer-sponsored benefits. - Through a flat, per-member, per-month subscription fee, employers can offer insulin to their employees with predictable, affordable, and transparent costs.
Read More

PatientsLikeMe Partners with LetsGetChecked to Offer Members Access to Home Testing Solutions

by Fred Pennic 12/19/2022 Leave a Comment

UnitedHealth Group Acquires Personalized Health Network PatientsLikeMe

What You Should Know: - PatientsLikeMe (PLM), the trusted community health network that empowers patients to take charge of their health, announced its partnership with LetsGetChecked, a global healthcare solutions company. - The partnership will provide PLM’s 1 million members with access to enhanced patient support capabilities for testing. PLM’s expansive patient community can now utilize LetsGetChecked’s suite of offerings directly through the PLM platform and receive a discount on
Read More

Healthcare Companies on the Stock Market

by HITC Staff 08/10/2022 Leave a Comment

Good healthcare and the financial sector cannot be separated entirely, even when their base motivations lie in different directions. While the medical sector should focus more on the health of the patients instead of consumerism, a good amount of capital is needed to ensure a functional system. Naturally, we can find healthcare companies on the stock market. Considering the continuous need for health care, that is not tied to market crashes the way other stocks are, this is a great chance for
Read More

Eli Lilly Partners with Yseop to Expedite Drug Approval Process

by Strategic Partnerships 05/18/2022 Leave a Comment

Eli Lilly Partners with Yseop to Expedite Drug Approval Process

What You Should Know: - Eli Lilly and Company partners with Yseop, an AI software company and pioneer in Natural Language Processing (NLP) to deploy Yseop’s world-class enterprise automation platform, Augmented Analyst, to accelerate bringing Lilly’s medicines to patients. - Yseop’s platform uses Natural Language Generation (NLG) to augment human analysis with automated insights. With Yseop’s powerful AI automation technology, teams can shorten the time spent on specialist medical reports
Read More

Glooko Integrates with Eli Lilly’s Connected Insulin Pen Solutions in Global Markets

by Fred Pennic 05/06/2021 Leave a Comment

Glooko Integrates with Eli Lilly’s Connected Insulin Pen Solutions in Global Markets

What We Should Know:  - Glooko Inc., a provider of remote patient monitoring and data management solutions for diabetes and other chronic conditions announced a strategic collaboration with Eli Lilly and Company for people with diabetes that use Lilly’s connected insulin pen solutions.   - The technology collaboration will ease insulin management for people with diabetes and their healthcare providers in markets outside the U.S., via integration of Lilly’s Tempo Pen™ and
Read More

Livongo for Diabetes Solution Now Available to New Jersey State and School Health Plan Members

by Fred Pennic 01/21/2020 Leave a Comment

State of Connecticut Launches of Livongo for Diabetes Management Program through State Health Plan

- Livongo forms partnership with Horizon Blue Cross Blue Shield of New Jersey and the State of New Jersey to provide Livongo for Diabetes to State and School Plan Members for 460k public employees and their dependents. - Livongo expects, after having been selected by the State of New Jersey in the fourth quarter of 2019, that this agreement will make approximately 29,000 people eligible for the Livongo for Diabetes program and add approximately 5,000 Members in 2020 as anticipated in the plan
Read More

Lilly to Integrate Dexcom CGMs into Personalized Diabetes Management System

by Jasmine Pennic 12/16/2019 Leave a Comment

diabetes management qualcomm medtronic diabetes

- Eli Lilly has announced a global commercialization agreement to integrate Dexcom’s continuous glucose monitoring (CGM) devices into Lilly’s personalized diabetes management system. - The personalized diabetes management system, currently in development to advance the treatment of diabetes, will integrate connected insulin delivery devices, software and analysis to equip people with diabetes and their healthcare providers with personalized information and guidance to help them better manage
Read More

  • Go to page 1
  • Go to page 2
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |